Dr Claire Townsend on behalf of EPPICC. Presented at the 2 nd International Workshop on HIV Pediatrics July 2010, Vienna Austria
|
|
- Melina Park
- 6 years ago
- Views:
Transcription
1 Response to early antiretroviral treatment in HIV-infected infants: the experience of the European Pregnancy & Paediatric HIV Cohort Collaboration (EPPICC) Dr Claire Townsend on behalf of EPPICC
2 Background Paediatric treatment guidelines now recommend initiation of ART in all HIVinfected infants regardless of clinical status, CD4 or viral load. Data on short-term immunological and virological responses to early treatment are limited.
3 Aims To describe first-line HAART regimens in infants in Europe. To investigate virological and immunological response to HAART at 6 and 12 months after initiation. Inclusion criteria: Born Diagnosed with HIV & started HAART <12m of age 9 months of follow-up
4 9 cohorts, 414 children Data n Percent UK / Ireland (NSHPC/CHIPS) % Italy (Italian Register) 94 23% France (EPF) 75 18% Others * 87 21% * Belgium (Hopital St Pierre), Romania (Victor Babes Hospital), Spain (CoRISPE-cat, Catalonia; Madrid Cohort), Switzerland (MoCHiV); European Collaborative Study.
5 Analysis Virological response / suppression Viral load <400 copies/ml Logistic regression CD4 response Absolute change in CD4 z-score from baseline Linear regression A priori predictors Type of HAART Age at initiation (<3, 3-5, 6+ months) Calendar year of initiation ( )
6 Baseline Characteristics (n=414) Percent Female 54% <3 38% Age at HAART initiation % (months) 6+ 24% Maternal ART in pregnancy 34% Infant neonatal prophylaxis 28% Breastfed 36% Pre-treatment AIDS diagnosis 29%
7 Trends in first-line HAART regimens 100% 11% 12% 6% 8% 80% 20% 60% 40% 66% 40% 8% 15% 41% 24% 20% 20% PI+NNRTI/Other unboosted PI boosted PI NNRTI + 3 NRTIs NNRTI + 2 NRTIs 20% 0% 30% 25% 30% 19% Year of HAART initiation
8 Proportion of children achieving virological suppression after 12 months of HAART % viral load<400c/ml 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 52% 56% 71% 85% Year of HAART initiation
9 Virological response at 12 months after HAART initiation - multivariable analysis (n=326) n AOR 95% CI p-value Year of HAART initiation per year , 1.3 <0.01 Type of HAART NNRTI + 2NRTIs NNRTI + 3NRTIs , 6.8 Boosted PI , 2.3 Unboosted PI , 1.2 PI+NNRTI / neither , No association with any other variables (age at initiation, cohort, gender, ethnic group, pre-treatment AIDS / CD4 z-score / viral load, maternal ART, neonatal prophylaxis, breastfeeding)
10 Change in CD4 z score after 12 months of HAART by baseline CD4 z score CD4 zscore increase (12m) CD4 z-score increase by 12m Median CD4 z-scores Baseline -1.5 (IQR -3.5, -0.5) 12 months -0.5 (IQR -1.3, 0.1) Increase 1.0 (IQR -0.3, 2.8) baseline CD4 zscore Baseline CD4 z-score
11 Change in CD4 z-score at 12 months after HAART initiation - multivariable linear regression (n=177) Coeff. 95% CI p-value Baseline CD4 z-score Per unit , -0.7 <0.001 Maternal ART in pregnancy No / not reported 0.0 Yes , -0.5 <0.001 No association with any other variables (HAART type, calendar year, age at initiation, gender, ethnic group, pre-treatment AIDS / viral load, neonatal prophylaxis, breastfeeding)
12 Conclusions Virological response to treatment improved substantially over time General improvements in HIV management and care Some differences in virological response by type of HAART Effectiveness of 4-drug regimens (ARROW trial) Baseline CD4 z-score was the main predictor of CD4 response
13 Further work Further analyses will explore duration of first-line regimens and reasons for stopping/switching treatment European experience of early HAART over 13 years Similar patterns in unselected populations where all children receive HAART?
14 Acknowledgements Writing Committee: Ali Judd and Martina Penazzato (projects leads), Hannah Castro and Claire Townsend (statisticians), Elena Chiappini and Luisa Galli (Italian Register for HIV Infection in Children), Diana Gibb (UK and Ireland Collaborative HIV Paediatric Study- CHIPS), Tessa Goetghebuer (Hopital St Pierre Cohort, Brussels, Belgium), Josiane Warszawski (French Perinatal Cohort- ANRS CO1 EPF). Contributing Cohorts: CHIPS (UK and Ireland); CoRISPE-cat (Catalonia, Spain); ECS (European Collaborative Study); Hopital St Pierre Cohort (Brussels, Belgium); ANRS CO1 EPF (France); Italian Register for HIV Infection in Children; Madrid Cohort of HIV-infected Children and Spanish Perinatal Cohort Study (Spain); MoCHiV (Swiss Mother and Child HIV Cohort Study); NSHPC (National Study of HIV in Pregnancy and Childhood, UK and Ireland); Victor Babes Hospital Cohort (Romania). EPPICC Cohorts Collaborators: Diana Gibb (CHIPS); Niels Valerius (Copenhagen Cohort, Denmark); Antoni Noguera-Julian (CoRISPE-cat); Claire Thorne (ECS); Tessa Goetghebuer (Hopital St Pierre Cohort); Josiane Warszawski (ANRS CO1 EPF); Vana Spoulou (Greece Cohort); Chris Koenings (KompNet, Germany); Maurizio de Martino (Italian Register); Jose T Ramos (Madrid Cohort of HIV-infected Children, and Spanish Perinatal Cohort Study); Mark Lallemant (PHPT, Thailand); Christoph Rudin (MoCHiV); Pat Tookey (NSHPC); Carlo Giaquinto (PENTA, Italy); Luminita Ene (Victor Babes Hospital Cohort); Magda Marczynska (Warsaw Cohort, Poland).
Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Ruth Goodall, Intira Jeannie Collins (MRC CTU at UCL), Luminita
More informationResponse to early antiretroviral therapy in HIV-1 infected infants in Europe,
Europe PMC Funders Group Author Manuscript Published in final edited form as: AIDS. 2011 November 28; 25(18): 2279 2287. doi:10.1097/qad.0b013e32834d614c. Response to early antiretroviral therapy in HIV-1
More informationAll HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis. Against the motion
All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis Against the motion Hermione Lyall Imperial Healthcare NHS Trust, London, UK Acknowledgements: Pat Tookey, Ali Judd, Claire
More informationHigh-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd
Adolescent transition to adult care: what do we know and research priorities High-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd Outline 1. What is transition? 2. Who is
More informationAntiretroviral Therapy During Pregnancy and Delivery: 2015 Update
Frontier AIDS Education and Training Center Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical Director,
More informationAcknowledgements Table of Contents About CIPHER CIPHER Paediatric Cohort Consultation Consultation Objectives...
ACKNOWLEDGEMENTS TABLE OF CONTENTS Acknowledgements... 1 Table of Contents... 2 About CIPHER... 4 CIPHER Paediatric Cohort Consultation... 5 Consultation Objectives... 5 Overview: Research Gaps... 5 Cohort
More informationInfertility Treatment and HIV
Infertility Treatment and HIV Infertility Treatment by IVF Or Intra-cytoplasmic Sperm Injections (ICSC) In Chronic HIV-1 Sero- discordant Couples (Poster 670) Retrospective study of outcome of IVF or ICSC
More informationPregnancy and HIV. Dr Annemiek de Ruiter. September 2009
Pregnancy and HIV Dr Annemiek de Ruiter September 2009 NSHPC NSHPC update, October 2008 Obstetric and paediatric HIV surveillance data from the UK and Ireland National Study of HIV in Pregnancy and Childhood
More informationIntira Jeannie Collins, Ruth Goodall, Colette Smith and Kara Wools-Kaloustian for the CIPHER Duration of First-Line Project Team.
Switch to second-line ART in HIV-infected children: a Collaborative Initiative for Paediatric HIV Education & Research (CIPHER) Global Cohort Collaboration analysis Intira Jeannie Collins, Ruth Goodall,
More informationDr Shema Tariq. City University London. 19 th Annual Conference of the British HIV Association (BHIVA)
19 th Annual Conference of the British HIV Association (BHIVA) Dr Shema Tariq City University London 16-19 April 2013, Manchester Central Convention Complex Loss to follow-up after pregnancy among women
More informationPreterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission
DOI: 10.1111/hiv.12083 SHORT COMMUNICATION Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission C-ES Short, 1,2 M Douglas, 2 JH Smith 2 and GP Taylor
More informationDr Sonia Raffe. Royal Sussex County Hospital, Brighton. 21 st Annual Conference of the British HIV Association (BHIVA)
21 st Annual Conference of the British HIV Association (BHIVA) Dr Sonia Raffe Royal Sussex County Hospital, Brighton 21-24 April 2015, The Brighton Centre 21 st Annual Conference of the British HIV Association
More informationThe availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings
Impact of the frequency of plasma viral load monitoring on treatment outcome among perinatally HIVinfected Asian children stable on first-line NNRTI-based cart T Sudjaritruk, DC Boettiger, NV Lam, KAM
More informationIs Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Co-infected Patients?
Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Co-infected Patients? Lars Peters for the hepatitis working group of COHERE in EuroCoord IMIT AMACS ECS-Mothers & ECS-Infants NSHPC-Mothers
More informationVirologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study.
Virologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study. K. Reichmuth 1, J. Nuttall, H. Rabie, B. Eley, H. Moultrie,
More informationA Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia
ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT
More information1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London
A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell
More informationQ and A - the PARTNER Study: new results from PARTNER 2
Q and A - the PARTNER Study: new results from PARTNER 2 1. Study results What is the PARTNER Study? The PARTNER study is an international two-phase study that looked at whether HIV transmission occurs
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationHighly active antiretroviral (ARV) therapy (HAART) has dramatically
ORIGINAL STUDIES Pattern and Predictors of Immunologic Recovery in Human Immunodeficiency Virus-Infected Children Receiving Non-Nucleoside Reverse Transcriptase Inhibitor-Based Highly Active Antiretroviral
More informationThe Danish HIV Cohort Study, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark 4
Antiviral Therapy 2009 14: 995 1000 (doi: 10.3851/IMP1412) Original article The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish
More informationAttrition and Treatment Outcomes among Perinatally and Behaviourally HIV-infected Adolescents and Youths in Thai National AIDS program
Attrition and Treatment Outcomes among Perinatally and Behaviourally HIV-infected Adolescents and Youths in Thai National AIDS program Sirinya Teeraananchai 1,2, Thanyawee Puthanakit 1,3,4, Suchada Chaivooth
More informationObstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
More informationTransient viral load increases in HIV-infected children in the UK and Ireland: what do they mean?
Transient viral load increases in HIV-infected children in the UK and Ireland: what do they mean? Katherine J Lee 1 *, Delane Shingadia 2, Deenan Pillay 3, A Sarah Walker 1, Andrew Riordan 4, Esse Menson
More informationChanges in cellular HIV DNA levels during the MONET trial: 144 Weeks of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
Changes in cellular HIV DNA levels during the MONET trial: 144 Weeks of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs Anna Maria Geretti, Jose R Arribas, Johan Vingerhoets, Geraldine Foster, Sabine
More informationD:A:D Study Teaching Material
D:A:D Study Teaching Material Data Collection of Adverse events of anti-hiv Drugs (D:A:D) study December 2012 - CHIP Background The D:A:D Study, is a prospective cohort study (collaboration) initiated
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationDr Laura Byrne. UCL Institute of Child Health, London
Dr Laura Byrne UCL Institute of Child Health, London RCOG, London Elimination of vertical transmission in the UK: what is left to do? Results of the NSHPC audit of perinatal HIV since 2006 Laura Byrne,
More informationHIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME
HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME SOUTHERN AFRICAN HIV CLINICIANS SOCIETY CONFERENCE - 2014 26 SEPTEMBER 2014 Khadija Jamaloodien Affordable Medicines ANTIMICROBIAL STEWARDSHIP The
More informationWomen and HIV. Dr Fatima Waziri Ibrahim Consultant in Sexual Health and HIV Medicine Leicester
Women and HIV Dr Fatima Waziri Ibrahim Consultant in Sexual Health and HIV Medicine Leicester Women and HIV Epidemiology Women and HIV Antiretroviral drugs Conception and contraception Pregnancy Long term
More informationBreast Feeding for Women with HIV?
Breast Feeding for Women with HIV? CHIVA / BHIVA Hermione Lyall Imperial Healthcare NHS Trust 17.11.17 Acknowledgements: Nell Freeman-Romilly, Pat Tookey, Claire Townsend, Claire Thorne, Kate Francis,
More informationHepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.
Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. Vana Papaevangelou (Greece) National and Kapodistrian University of Athens Chang SemFNM
More informationPurpose Methods Demographics of patients in the study Outcome. Efficacy Adverse Event. Limitation
ANDREW LEE Purpose Methods Demographics of patients in the study Outcome Efficacy Adverse Event Limitation Dolutegravir Integrase inhibitor Plasma half life 14hours Tivicay FDA (US)- 13 August 2013 50mg
More informationIAS 2013 Towards an HIV Cure Symposium
In chronically HIV-1-infected patients long-term antiretroviral therapy initiated above 500 CD4/mm 3 achieves better HIV-1 reservoirs' depletion and T-cell count restoration IAS 2013 Towards an HIV Cure
More informationGESIDA 2018 ANTIRETROVIRAL TREATMENT MAINTENANCE STRATEGIES AND BLOOD TELOMERE LENGTH CHANGE
ANTIRETROVIRAL TREATMENT MAINTENANCE STRATEGIES AND BLOOD TELOMERE LENGTH CHANGE Rocío Montejano 1, Natalia Stella-Ascariz 1, Susana Monge 1, Jose I Bernardino 1, Ignacio Perez-Valero 1, Marisa Montes
More informationRepeat Pregnancies and HIV Care Engagement among Postpartum HIV-infected Women in Atlanta, Georgia,
Repeat Pregnancies and HIV Care Engagement among Postpartum HIV-infected Women in Atlanta, Georgia, 2011-2015 Anandi N. Sheth, Christina M. Meade, Martina Badell, Susan A. Davis, Stephanie Hackett, Joy
More informationHIV-HBV coinfection in HIV population horizontally infected in early childhood between
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin
More informationEvaluating an enhanced adherence intervention among HIV positive adolescents failing 2 nd line treatment
Evaluating an enhanced adherence intervention among HIV positive adolescents failing 2 nd line treatment Tariro D Chawana MBChB (UZ), MSc Clinical Pharmacology (UZ), DPhil student None Conflict of interest
More informationFactors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa
Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa Dvora Joseph Davey 1, 2, PhD, Zulfa Abrahams 2, PhD 1 BroadReach, South Africa
More informationOriginal article Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission
Antiviral Therapy 2 5:775 783 (doi:.385/imp63 Original article Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission Claire L Townsend
More informationHIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression
HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression Nicholas Musinguzi on behalf of Jose Castillo-Mancila,
More informationSupervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles
I Congreso de GESIDA Madrid, 21-24 de Octubre del 2009. Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles José M. Miró, 1 Miguel Montejo,
More informationSupplemental Digital Content 1. Combination antiretroviral therapy regimens utilized in each study
Supplemental Digital Content 1. Combination antiretroviral therapy regimens utilized in each study Study Almeida 2011 Auld 2011 Bassett 2012 Bastard 2012 Boulle 2008 (a) Boulle 2008 (b) Boulle 2010 Breen
More informationSafety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients aged 3 to <6 years: Week 48 analysis of the ARIEL trial
Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients aged 3 to
More informationGLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW
GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW TOWARDS AN CURE PEOPLE FOCUSED SCIENCE DRIVEN JULY 2018 A GLOBAL STRATEGIC APPROACH TOWARDS
More informationNew Directions on WHO ARV Guidelines 2018
New Directions on WHO ARV Guidelines 2018 Elaine Abrams Co-chair WHO Guidelines Development Group ICAP at Columbia University, New York Martina Penazzato Paediatric lead for the HIV Department World Health
More informationDr Graham P Taylor Reader in Communicable Diseases
HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum
More informationThe importance of cohort collaborations for guiding clinical management of individuals with HIV infection
The importance of cohort collaborations for guiding clinical management of individuals with HIV infection Caroline Sabin Professor of Medical Statistics and Epidemiology Royal Free and University College
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationResearch Article The Use of Protease Inhibitors in Pregnancy: Maternal and Fetal Considerations
Infectious Diseases in Obstetrics and Gynecology Volume 2015, Article ID 563727, 5 pages http://dx.doi.org/10.1155/2015/563727 Research Article The Use of Protease Inhibitors in Pregnancy: Maternal and
More informationHIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI
HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV
More informationUganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.50 Demographic and socioeconomic data Uganda HIV Country Pro le: 2017 42.9 million Total population (2017) 1 820 US$ GNI per capita, PPP (2017) 343 Maternal mortality per 100 000 live births
More informationCote D'Ivoire. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.50 Demographic and socioeconomic data Cote D'Ivoire HIV Country Pro le: 2017 24.3 million Total population (2017) 3 820 US$ GNI per capita, PPP (2017) 645 Maternal mortality per 100 000
More informationCD4 Assays Are No Longer Needed for Care of Children in Low-resource Countries. The case against Di Gibb
CD4 Assays Are No Longer Needed for Care of Children in Low-resource Countries The case against Di Gibb The value of CD4 Pre-ART CD4 CD4 monitoring on ART Pre-ART CD4 for linkage to care & clinical management
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationSecond and third line paediatric ART strategies
Second and third line paediatric ART strategies Dr. Marape Marape Assistant Professor Ohio University School of Health Professions Gaborone, Botswana Marape Marape MB, BCh, BAO, MPH, PhD Assistant Professor
More informationGenital Tract Infections in HIV- Infected Pregnant Women in South West London
Genital Tract Infections in HIV- Infected Pregnant Women in South West London A Hegazi, N Ramskill, M Norbrook, E Dwyer, S Milne, B Nathan, S Esterich, A ElGalib, T Morgan, A Barbour, P Hay St George s
More informationPediatric HIV Cure Research
Pediatric HIV Cure Research HIV Cure Research Training Curriculum Pediatric HIV Cure Research Presented by: Priyanka Uprety,MSPH, PhD Laboratory of Deborah Persaud, MD Johns Hopkins University July 2016
More informationLifelong Monitoring of HIV-Exposed Uninfected Infants is CRUCIAL! Jennifer Jao, MD, MPH Icahn School of Medicine at Mount Sinai
Lifelong Monitoring of HIV-Exposed Uninfected Infants is CRUCIAL! Jennifer Jao, MD, MPH Icahn School of Medicine at Mount Sinai Increasing numbers of HEUs Worldwide 1.800.000 1.600.000 1.400.000 1.200.000
More informationWhat s New. In The 2016 Perinatal HIV Treatment Guidelines? Provided by CDC s Elimination of Perinatal HIV Transmission Stakeholders Group
What s New In The 2016 Perinatal HIV Treatment Guidelines? Provided by CDC s Elimination of Perinatal HIV Transmission Stakeholders Group Guidelines for our Online Meeting Room You will be listening to
More informationSTRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA
STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious
More informationPeter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1
OUTCOMES OF HIV EXPOSED INFANTS BEFORE AND AFTER IMPLEMENTING OPTION B+ PMTCT GUIDELINE IN KAMPALA,UGANDA: A RETROSPECTIVE COHORT STUDY. Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang
More informationThe effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors
The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors Aura Temereanca 1,2, Luminita Ene 3, Adelina Rosca
More informationThe European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord
European Journal of Public Health, 1 6 ß The Author 2017. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:10.1093/eurpub/ckx048... Migrant
More informationPediatric Antiretroviral Resistance Challenges
Pediatric Antiretroviral Resistance Challenges Thanyawee Puthanakit, MD The HIVNAT, Thai Red Cross AIDS research Center The Research Institute for Health Science, Chiang Mai University Outline The burden
More informationDOI: /hiv on behalf of British HIV Association. HIV Medicine (2015) ORIGINAL RESEARCH
DOI: 10.1111/hiv.12217. ORIGINAL RESEARCH Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult
More informationNote: for non-commercial purposes only
Impact of maternal body mass index before pregnancy on growth trajectory patterns in childhood and body composition in young adulthood WP10 working group of the Early Nutrition Project Wendy H. Oddy,*
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationWHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES?
WHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES? Today s Webinar will be starting soon For the audio portion of this meeting: Dial 1-855-702-5382 Enter participant code 596-825-4701# Guidelines for online
More informationDuration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study
DOI: 10.1111/1471-0528.13442 www.bjog.org General obstetrics Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study H Peters, a L Byrne,
More informationAnumber of clinical trials have demonstrated
IMPROVING THE UTILITY OF PHENOTYPE RESISTANCE ASSAYS: NEW CUT-POINTS AND INTERPRETATION * Richard Haubrich, MD ABSTRACT The interpretation of a phenotype assay is determined by the cut-point, which defines
More informationFrailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi
Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting Giovanni Guaraldi Potential conflicts of interest Research funding: Jansen, Gilead, MSD, BMS Consultancies:
More informationFinal recommendations. WHO Paediatric Guideline Group meeting Geneva, SWITZERLAND Salle D April 2008
Final recommendations WHO Paediatric Guideline Group meeting Geneva, SWITZERLAND Salle D 10-11 April 2008 Population Reco HIV-exposed infants Virological testing at 4-6 weeks of age When to Test HIV exposure
More informationPediatric Antiretroviral Therapy
Update on Pediatric Antiretroviral Therapy Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch National Institute of Child Health and Human Development National Institutes of Health
More informationPhase II clinical trial TEmAA. Didier Koumavi EKOUEVI, MD PhD (Principal Investigator)
The combination of Tenofovir-Emtricitabine (Truvada ): a new antiretroviral (ARV) regimen for the prevention of mother-to-child transmission of HIV-1 (PMTCT) in resource-limited settings Phase II clinical
More informationWHO HIV Drug Resistance Strategy
WHO HIV Drug Resistance Strategy Boston, 27 February 2011 Background Global ART scale-up has been a remarkable achievement benefiting over 5.2 million individuals in resource limited settings Maintaining
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationCalifornia Perinatal Quality Care Collaborative 2013 Standards of Care for the Prevention of Perinatal HIV Transmission
2013 Revised Edition Authors: David K Hong, MD, Nivedita Srinivas, MD Original Authors: Mary Campbell Bliss, RN, MS, CNS, William Gilbert, MD, Jan Lanouette, MD, Courtney Nisbet, RN, MS, David Wirtschafter,
More informationPregnancy and HIV Reviewing the Vertical Transmission Risks 2015 OCN Education Day V Logan Kennedy RN, MN Research Associate and Clinical Nursing
Pregnancy and HIV Reviewing the Vertical Transmission Risks 2015 OCN Education Day V Logan Kennedy RN, MN Research Associate and Clinical Nursing Specialist Women s College Research Institute, Women s
More informationVitamin D Deficiency in HIV: A Shadow on Long-Term Management?
AIDS Rev. 2014;16:59-74 (Supplementary Data) Vitamin D Deficiency in HIV: A Shadow on Long-Term Management? Chloe Orkin, et al.: Vitamin D deficiency in HIV (Supplementary Data) Chloe Orkin 1, David A.
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationOriginal article Duration of first-line antiretroviral therapy in HIVinfected treatment-naive patients in routine practice
Antiviral Therapy 2016; 21:715 724 (doi: 10.3851/IMP3084) Original article Duration of first-line antiretroviral therapy in HIVinfected treatment-naive patients in routine practice Thomas Tesson 1, Mathieu
More informationEvaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke
Journal of Infectious Diseases Advance Access published January 5, 2012 BRIEF REPORT Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke S. W. Worm, 1 D. A. Kamara,
More informationEffect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community of central Nigeria
Niger J Paed 2014; 41 (1): 1-6 Ebonyi AO Oguche S Dablets E Sumi B Yakubu E Sagay AS ORIGINAL Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community
More informationInfluence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals
Influence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals Christoph Boesecke, Hans-Jürgen Stellbrink, Stefan Mauss, Emma Page, Mark Nelson, Sanjay
More informationHigher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe
DOI: 10.1111/hiv.12411 ORIGINAL RESEARCH Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe A Judd, 1 R
More informationWhole genome deep sequencing of HIV reveals extensive multi-class drug resistance in Nigerian patients failing first-line antiretroviral therapy
Whole genome deep sequencing of HIV reveals extensive multi-class drug resistance in Nigerian patients failing first-line antiretroviral therapy K El Bouzidi 1,, RP Datir 1, V Kwaghe 3, S Roy 1, D Frampton
More informationDownloaded from:
Gibb, DM; Duong, T; Tookey, PA; Sharland, M; Tudor-Williams, G; Novelli, V; Butler, K; Riordan, A; Farrelly, L; Masters, J; Peckham, CS; Dunn, DT (2003) Decline in mortality, AIDS, and hospital admissions
More informationBotswana. HIV Country Profile: Health expenditure, total (% of GDP) (2016) Total fertility rate (births per woman) ( )
WHO/CDS/HIV/18.5 Demographic and socioeconomic data Botswana HIV Country Profile: 217 2.3 million Total population (217) 16 99 US$ GNI per capita, PPP (217) World Bank 129 Maternal mortality per 1 live
More informationPharmacovigilance of highly active antiretroviral therapy among adult patients in a large urban HIV treatment center in Nigeria
Abstract no. A-641-0120-07827 Pharmacovigilance of highly active antiretroviral therapy among adult patients in a large urban HIV treatment center in Nigeria I.O. Abah 1, P. Ugoagwu, V. Ojeh, L. Ogwuche,
More informationPREGNANCY OUTCOMES AMONG HIV-INFECTED WOMEN IN UGANDA AND ZIMBABWE
PREGNANCY OUTCOMES AMONG HIV-INFECTED WOMEN IN UGANDA AND ZIMBABWE Kathryn Lancaster, MPH 3rd International Workshop on HIV & Women January 15, 2013 HIV among women of reproductive age Women of reproductive
More informationRisk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women...
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/40908390 Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active
More information15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy
15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy Lecturer Ana Maria TudorMD PhD * Mariana Mărdărescu MD PhD * Professor Ioana Anca MD PhD * * National Institute for Infectious
More information3rd IAS Conference on HIV Pathogenesis and Treatment. Poster Number Abstract #
3rd IAS Conference on HIV Pathogenesis and Treatment 24 27 July 2005, Rio de Janeiro, Brazil Poster Number Abstract # TuFo0106 TuFo0106 Characterization of Anemia in HIV-infected (HIV+) Subjects Treated
More informationImpact of infant feeding on growth trajectory patterns in childhood and body composition in young adulthood
Impact of infant feeding on growth trajectory patterns in childhood and body composition in young adulthood WP10 working group of the Early Nutrition Project Peter Rzehak*, Wendy H. Oddy,* Maria Luisa
More informationEswatini. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.5 Demographic and socioeconomic data Eswatini HIV Country Pro le: 217 1.4 million Total population (217) 8 52 US$ GNI per capita, PPP (217) World Bank 389 Maternal mortality per 1 live births
More informationHIV and Paediatrics in Central Europe
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in
More informationThe European network for paediatric research. Carlo Giaquinto University of Padova Padova
The European network for paediatric research Carlo Giaquinto University of Padova Padova Types of Paediatric networks (examples) Clinical Trials networks: National networks (MCRN, FinPedMed, CICPed, PaedNet
More informationAnna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma
Anna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma Research & Early Discovery Funding: Wellcome Trust, National
More information